Chen Mingxing – Trademark Portfolio

Entity Type: 01

Chen Mingxing holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 6 (Metal Goods) — 3 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include TOKPAC, ZOMYTO, HPESSOK, and ZIPOMET. The owner is based in Hunan.

No.016, Group 14, Ziyuan Village

Meiyuan Development Zone, Xinhua County

Hunan 417615 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TOKPAC
TOKPAC
Registered 2021
ZIPOMET
ZIPOMET
Registered 2021
ZOMYTO
ZOMYTO
Registered 2021
HPESSOK
HPESSOK
Registered 2019

Trademark Classifications

Chen Mingxing's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

6
Metal Goods (3 filings)

Common metals and their alloys; metal building materials; transportable buildings of metal

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Chen Mingxing have?

Chen Mingxing has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Chen Mingxing file in?

Chen Mingxing files trademarks across 2 Nice Classification classes. The most active classes are Class 6 (Metal Goods), Class 25 (Clothing). Class 6 covers common metals and their alloys; metal building materials; transportable buildings of metal.

What are Chen Mingxing's most well-known trademarks?

Chen Mingxing's registered trademark portfolio includes well-known marks such as TOKPAC, ZOMYTO, HPESSOK, and ZIPOMET. These are among 4 currently registered trademarks in the portfolio.

What is Chen Mingxing's trademark registration success rate?

Chen Mingxing has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.